Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes. [electronic resource]
Producer: 20010405Description: 283-7 p. digitalISSN:- 0026-0495
- Acute-Phase Proteins -- analysis
- Blood Glucose -- analysis
- Blood Proteins -- analysis
- C-Reactive Protein -- analysis
- Complement Activation -- physiology
- Complement C3 -- analysis
- Complement C3a -- analogs & derivatives
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Female
- Glyburide -- therapeutic use
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- therapeutic use
- Male
- Middle Aged
- Osmolar Concentration
- Pioglitazone
- Thiazoles -- therapeutic use
- Thiazolidinediones
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.